Capital Research Global Investors 13D/13G Filings for Praxis Precision Medicines, Inc. (PRAX)

Capital Research Global Investors 13D and 13G filings for Praxis Precision Medicines, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-11-12
1:29 pm
Purchase
2024-11-0713GPraxis Precision Medicines, Inc.
PRAX
Capital Research Global Investors997,094
5.600%
997,094increase
(New Position)
Filing